摘要
目的探究子宫腺肌症采用左炔诺孕酮宫内缓释系统治疗的临床疗效。方法选取42例子宫腺肌症患者,均采用左炔诺孕酮宫内缓释系统治疗,分析临床疗效。结果治疗后患者痛经评分、月经量、子宫体积、Hb(血红蛋白浓度)以及CA125(糖类抗原125)等均优于治疗前(P<0.05)。结论子宫腺肌症采用左炔诺孕酮宫内缓释系统治疗效果显著。
Objective The clinical curative effect of adenomyosis treated with levonorgestrel releasing intrauterine system.Methods Select 42 cases of patients with uterine gland muscle disease,al the levonorgestrel releasing intrauterine system in the treatment,to observe and compare the clinical indexes of patients before and after treatment.ResultsAfter treatment, dysmenorrhea score, menstrual volume, uterine volume, Hb （hemoglobin concentration） and CA125 （carbohydrate antigen 125） were superior to those of the treatment （P 〈 0.05）. ConclusionAdenomyosis of levonorgestrel releasing intrauterine system in the treatment effect is significant.
出处
《中国卫生标准管理》
2015年第23期110-111,共2页
China Health Standard Management
关键词
子宫腺肌症
左炔诺孕酮宫内缓释系统
临床疗效
Uterine gland muscle disease
The levonorgestrel releasing intrauterine system
Clinical curative effect
